+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Phenotype profile of blood lymphocytes in bronchiolitis obliterans after lung transplantation



Phenotype profile of blood lymphocytes in bronchiolitis obliterans after lung transplantation



Annales Pharmaceutiques Francaises 51(3): 125-134



Bronchiolitis obliterans (BO) remains the major complication in long-term survivors with lung transplants, occurring in up to 30% of them. As a non-invasive follow-up of lung recipients, we studied the phenotype of peripheral blood lymphocyte subsets. Using a flow cytometric analysis, we could define a specific pattern during BO. The most important findings were 1) disappearance of the CD19+ B cell population, despite normal or increased immunoglobulin blood levels; 2) marked decrease of the CD4+/CD8+ ratio; 3) dramatic increase in phenotypic cytotoxic effector T cells CD8+S6F1+ (MHC Class I-restricted allocytotoxicity) and CD3+CD4-CD8- (MHC Class I-non restricted allocytotoxicity); 4) marked increase of the CD4+CD29+ (helper/inducer T cell) to CD4+CD45RA+ (suppressor/inducer T cell) ratio associated with the loss of phenotypic suppressor/inducer CD4+CD45RA+ T cells. Moreover, we have shown that the maintenance triple immunosuppressive regimen that consisted of cyclosporin, prednisolone and azathioprine, did not affect the relative distribution of lymphocyte subsets, except for the CD3+CD4-CD8- cytotoxic subset that was slightly decreased under therapy. Thus, using a selected combination of lymphocyte membrane antigens, sequential prospective testing should be useful in the non-invasive follow-up of lung-transplanted patients to predict and halt the progressive course towards BO.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 046973705

Download citation: RISBibTeXText

PMID: 8250490


Related references

Living-donor lobar lung transplantation for broncho-bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation: does bronchiolitis obliterans recur in transplanted lungs?. International Journal of Hematology 86(4): 369-373, 2007

Postinfectious bronchiolitis obliterans in children: lessons from bronchiolitis obliterans after lung transplantation and hematopoietic stem cell transplantation. Korean Journal of Pediatrics 58(12): 459-465, 2015

Particular phenotypic profile of blood lymphocytes during obliterative bronchiolitis syndrome following lung transplantation. Transplant Immunology 2(3): 243-251, 1994

Lung transplantation biopsy specimens with bronchiolitis obliterans or bronchiolitis obliterans organizing pneumonia due to aspiration. Archives of Pathology & Laboratory Medicine 129(2): 223-226, 2005

What we expected all along: Bronchiolitis obliterans syndrome is not specific for bronchiolitis obliterans in pediatric lung transplantation!. Journal of Heart and Lung Transplantation 34(4): 501-502, 2015

Follicular bronchiolitis: a rare cause of bronchiolitis obliterans syndrome after lung transplantation: a case report. American Journal of Transplantation 9(3): 644-650, 2009

De novo HLA antibodies and lymphocytic bronchiolitis are significantly correlated with bronchiolitis obliterans syndrome in lung transplantation. Journal of Heart & Lung Transplantation 23(2S): S44, 2004

Does bronchial artery revascularization influence results concerning bronchiolitis obliterans syndrome and/or obliterative bronchiolitis after lung transplantation?. European Journal of Cardio-Thoracic Surgery 14(3): 311-318, 1998

Aerosol bolus dispersion in patients with bronchiolitis obliterans after heart-lung and double-lung transplantation. The Munich Lung Transplantation Group. Journal of Aerosol Medicine 11(1): 41-53, 1998

Detection of Epstein-Barr virus DNA in peripheral blood is associated with the development of bronchiolitis obliterans syndrome after lung transplantation. Journal of Clinical Virology 45(1): 47-53, 2009

Profiling of peripheral blood mononuclear cells does not accurately predict the bronchiolitis obliterans syndrome after lung transplantation. Transplant Immunology 32(3): 195-200, 2015

Conversion to sirolimus and mycophenolate can attenuate the progression bronchiolitis obliterans syndrome and improves renal lung transplantation fuunction after lung transplantation. Transplantation 81(3): 355-360, 2006

Bronchiolitis obliterans syndrome (BOS), bronchiolitis obliterans organizing pneumonia (BOOP), and other late-onset noninfectious pulmonary complications following allogeneic hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation 13(7): 749-759, 2007

Bronchiolitis obliterans syndrome is not specific for bronchiolitis obliterans in pediatric lung transplant. Journal of Heart and Lung Transplantation 34(4): 516-521, 2015

Evidence for oxidative stress in bronchiolitis obliterans syndrome after lung and heart-lung transplantation. The Munich Lung Transplant Group. Transplantation 69(9): 1856-1860, 2000